|
Originally published In Press as doi:10.1074/jbc.R700002200 on March 29, 2007
J. Biol. Chem., Vol. 282, Issue 21, 15325-15329, May 25, 2007
Minireview
Triggering the Innate Antiviral Response through IRF-3 Activation*
John Hiscott1
From the
Lady Davis Institute for Medical Research-Jewish General Hospital, Departments of Microbiology & Immunology, Medicine, and Oncology, McGill University, Montreal H3T 1E2, Canada
Rapid induction of type I interferon (IFN) expression is a central event in the establishment of the innate immune response against viral infection and requires the activation of multiple transcriptional proteins following engagement and signaling through Toll-like receptor-dependent and -independent pathways. The transcription factor interferon regulatory factor-3 (IRF-3) contributes to a first line of defense against viral infection by inducing the production of IFN- that in turn amplifies the IFN response and the development of antiviral activity. In murine knock-out models, the absence of IRF-3 and the closely related IRF-7 ablates IFN production and increases viral pathogenesis, thus supporting a pivotal role for IRF-3/IRF-7 in the development of the host antiviral response.
* This minireview will be reprinted in the 2007 Minireview Compendium, which will be available in January, 2008. This research was supported by grants from the Canadian Institutes of Health Research (CIHR), the National Cancer Institute of Canada, with the support of the Canadian Cancer Society, and CANFAR, the Canadian Foundation for AIDS Research. This is the third article of three in the Innate Immunity Minireview Series.
1 Supported by a CIHR Senior Investigator award. To whom correspondence should be addressed. E-mail: john.hiscott{at}mcgill.ca.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. Genin, R. Lin, J. Hiscott, and A. Civas
Differential Regulation of Human Interferon A Gene Expression by Interferon Regulatory Factors 3 and 7
Mol. Cell. Biol.,
June 15, 2009;
29(12):
3435 - 3450.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-L. Siu, K.-H. Kok, M.-H. J. Ng, V. K. M. Poon, K.-Y. Yuen, B.-J. Zheng, and D.-Y. Jin
Severe Acute Respiratory Syndrome Coronavirus M Protein Inhibits Type I Interferon Production by Impeding the Formation of TRAF3{middle dot}TANK{middle dot}TBK1/IKK{epsilon} Complex
J. Biol. Chem.,
June 12, 2009;
284(24):
16202 - 16209.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nociari, O. Ocheretina, M. Murphy, and E. Falck-Pedersen
Adenovirus Induction of IRF3 Occurs through a Binary Trigger Targeting Jun N-Terminal Kinase and TBK1 Kinase Cascades and Type I Interferon Autocrine Signaling
J. Virol.,
May 1, 2009;
83(9):
4081 - 4091.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Sly, M. J. Hamilton, E. Kuroda, V. W. Ho, F. L. Antignano, S. L. Omeis, C. J. van Netten-Thomas, D. Wong, H. K. Brugger, O. Williams, et al.
SHIP prevents lipopolysaccharide from triggering an antiviral response in mice
Blood,
March 26, 2009;
113(13):
2945 - 2954.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Giacomini, M. E. Remoli, V. Gafa, M. Pardini, L. Fattorini, and E. M. Coccia
IFN-{beta} improves BCG immunogenicity by acting on DC maturation
J. Leukoc. Biol.,
March 1, 2009;
85(3):
462 - 468.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-T. Wang, S.-L. Doong, S.-C. Teng, C.-P. Lee, C.-H. Tsai, and M.-R. Chen
Epstein-Barr Virus BGLF4 Kinase Suppresses the Interferon Regulatory Factor 3 Signaling Pathway
J. Virol.,
February 15, 2009;
83(4):
1856 - 1869.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Miyahira, A. Shahangian, S. Hwang, R. Sun, and G. Cheng
TANK-Binding Kinase-1 Plays an Important Role during In Vitro and In Vivo Type I IFN Responses to DNA Virus Infections
J. Immunol.,
February 15, 2009;
182(4):
2248 - 2257.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Wu, E. Fossum, C. H. Joo, K.-S. Inn, Y. C. Shin, E. Johannsen, L. M. Hutt-Fletcher, J. Hass, and J. U. Jung
Epstein-Barr Virus LF2: an Antagonist to Type I Interferon
J. Virol.,
January 15, 2009;
83(2):
1140 - 1146.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-L. Li, H. J. Ezelle, T.-J. Kang, L. Zhang, K. A. Shirey, J. Harro, J. D. Hasday, S. K. Mohapatra, O. R. Crasta, S. N. Vogel, et al.
An essential role for the antiviral endoribonuclease, RNase-L, in antibacterial immunity
PNAS,
December 30, 2008;
105(52):
20816 - 20821.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Zhang and C. E. Samuel
Induction of Protein Kinase PKR-dependent Activation of Interferon Regulatory Factor 3 by Vaccinia Virus Occurs through Adapter IPS-1 Signaling
J. Biol. Chem.,
December 12, 2008;
283(50):
34580 - 34587.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Prele, E. A. Woodward, J. Bisley, A. Keith-Magee, S. E. Nicholson, and P. H. Hart
SOCS1 Regulates the IFN but Not NF{kappa}B Pathway in TLR-Stimulated Human Monocytes and Macrophages
J. Immunol.,
December 1, 2008;
181(11):
8018 - 8026.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Vogt, E. Preuss, D. Mayer, F. Weber, M. Schwemmle, and G. Kochs
The Interferon Antagonist ML Protein of Thogoto Virus Targets General Transcription Factor IIB
J. Virol.,
November 15, 2008;
82(22):
11446 - 11453.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Fensterl, C. L. White, M. Yamashita, and G. C. Sen
Novel Characteristics of the Function and Induction of Murine p56 Family Proteins
J. Virol.,
November 15, 2008;
82(22):
11045 - 11053.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Alff, N. Sen, E. Gorbunova, I. N. Gavrilovskaya, and E. R. Mackow
The NY-1 Hantavirus Gn Cytoplasmic Tail Coprecipitates TRAF3 and Inhibits Cellular Interferon Responses by Disrupting TBK1-TRAF3 Complex Formation
J. Virol.,
September 15, 2008;
82(18):
9115 - 9122.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Daffis, M. A. Samuel, M. S. Suthar, B. C. Keller, M. Gale Jr., and M. S. Diamond
Interferon Regulatory Factor IRF-7 Induces the Antiviral Alpha Interferon Response and Protects against Lethal West Nile Virus Infection
J. Virol.,
September 1, 2008;
82(17):
8465 - 8475.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Le Tortorec, H. Denis, A-P. Satie, J-J. Patard, A. Ruffault, B. Jegou, and N. Dejucq-Rainsford
Antiviral responses of human Leydig cells to mumps virus infection or poly I:C stimulation
Hum. Reprod.,
September 1, 2008;
23(9):
2095 - 2103.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Bitko, A. Musiyenko, M. A. Bayfield, R. J. Maraia, and S. Barik
Cellular La Protein Shields Nonsegmented Negative-Strand RNA Viral Leader RNA from RIG-I and Enhances Virus Growth by Diverse Mechanisms
J. Virol.,
August 15, 2008;
82(16):
7977 - 7987.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Higgs, J. N. Gabhann, N. B. Larbi, E. P. Breen, K. A. Fitzgerald, and C. A. Jefferies
The E3 Ubiquitin Ligase Ro52 Negatively Regulates IFN-{beta} Production Post-Pathogen Recognition by Polyubiquitin-Mediated Degradation of IRF3
J. Immunol.,
August 1, 2008;
181(3):
1780 - 1786.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Saito and M. Gale Jr.
Differential recognition of double-stranded RNA by RIG-I-like receptors in antiviral immunity
J. Exp. Med.,
July 7, 2008;
205(7):
1523 - 1527.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. L. Lu, M. Puri, C. M. Horvath, and G. C. Sen
Select Paramyxoviral V Proteins Inhibit IRF3 Activation by Acting as Alternative Substrates for Inhibitor of {kappa}B Kinase {epsilon} (IKKe)/TBK1
J. Biol. Chem.,
May 23, 2008;
283(21):
14269 - 14276.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Zhang, B. L. Jacobs, and C. E. Samuel
Loss of Protein Kinase PKR Expression in Human HeLa Cells Complements the Vaccinia Virus E3L Deletion Mutant Phenotype by Restoration of Viral Protein Synthesis
J. Virol.,
January 15, 2008;
82(2):
840 - 848.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-M. Loo, J. Fornek, N. Crochet, G. Bajwa, O. Perwitasari, L. Martinez-Sobrido, S. Akira, M. A. Gill, A. Garcia-Sastre, M. G. Katze, et al.
Distinct RIG-I and MDA5 Signaling by RNA Viruses in Innate Immunity
J. Virol.,
January 1, 2008;
82(1):
335 - 345.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Kayagaki, Q. Phung, S. Chan, R. Chaudhari, C. Quan, K. M. O'Rourke, M. Eby, E. Pietras, G. Cheng, J. F. Bazan, et al.
DUBA: A Deubiquitinase That Regulates Type I Interferon Production
Science,
December 7, 2007;
318(5856):
1628 - 1632.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Samuel
Interferons, Interferon Receptors, Signal Transducer and Transcriptional Activators, and Interferon Regulatory Factors
J. Biol. Chem.,
July 13, 2007;
282(28):
20045 - 20046.
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|